Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-012039

Director acquired 46,296 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hayden Michael R · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-16 Exercise or conversion : show line 1 in the form +5,144 $2.68 $13,786 112,706 D
2021-02-18 Exercise or conversion : show line 2 in the form +10,288 $3.67 $37,757 61,212 I
2021-02-18 Exercise or conversion : show line 3 in the form +30,864 $2.68 $82,716 92,076 I

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-02-16 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −5,144 0 D
2021-02-18 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −10,288 0 I
2021-02-18 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −30,864 0 I
Loading xslF345X03/doc4.xml…